SPDR S&P Biotech ETF (XBI) is falling as the risk-off trade persists.
Our XBI Jan Week Two (1/14) 105 Call is on track to expire worthless. We will simply watch it do so and sell another call soon to reduce our cost basis on the position.
Current Stock Price: $96.84
Cost Basis: $109.58
Action: Watch call expire worthless